Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.45 USD | -2.02% |
|
-0.97% | -65.24% |
05:43pm | Barclays Cuts Price Target on 10x Genomics to $24 From $36, Maintains Overweight Rating | MT |
06-27 | Wolfe Research Downgrades 10x Genomics to Peer Perform From Outperform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.24% | 2.38B | |
-11.78% | 11.41B | |
-13.76% | 7.4B | |
+29.50% | 5.64B | |
-0.19% | 5.33B | |
-19.19% | 3.7B | |
+7.62% | 2.58B | |
-10.48% | 2.2B | |
+27.80% | 2.2B | |
-19.12% | 1.62B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- Guggenheim Downgrades 10x Genomics to Neutral From Buy